Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Undenatured type II collagen (UC-II)

Undenatured Type II Collagen (UC-II) · also known as UC-II, Undenatured type 2 collagen, Active type II collagen, Oral tolerance collagen

Undenatured type II collagen comes from chicken sternal (breastbone) cartilage and keeps its native triple-helix structure. Animal studies show that taken orally it can induce immune tolerance and reduce cartilage degeneration. One randomized human trial found improvement in some symptoms, but the oral tolerance mechanism has not been confirmed in humans.

Typical dose: 40 mg/day. Strengths differ, so check the label for the undenatured type II collagen content. There is not enough evidence behind the advice to take it at bedtime or on an empty stomach. Follow the product directions, and do not take it with very hot water.
Absorption and forms: The daily amount of this product is 40 mg, in contrast to commonly used hydrolyzed collagen peptides. The amount of undenatured type II collagen differs between products, and some are labeled 10 mg, so go by the product label. Avoid high heat when taking it so that the native triple-helix structure is not damaged.

Clinical uses and human evidence

Osteoarthritis pain

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Lugo 2016 · Nutr J · RCT · n=191 — Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study

Mechanisms of action

Mucosal oral immune tolerance (Treg induction in Peyer’s patches)

★★★☆☆Mechanism evidence: grade CPrimary target

Mouse studies showed that after oral type II collagen, Peyer’s patch dendritic cells and Foxp3+ regulatory T cells take part in immune tolerance, which makes this a candidate mechanism with animal evidence behind it. Animal models are not fully equivalent to this product or to human osteoarthritis, and uptake by Peyer’s patches has not been confirmed in humans.

References (2)
  1. Park 2008 · Mouse collagen-induced arthritis study: after oral type II collagen, Peyer’s patch dendritic cells and Foxp3+ regulatory T cells took part in immune tolerance.
  2. Lugo 2016 · Human RCT: UC-II improved some symptoms, but the antigen-specific Treg mechanism was not directly confirmed.

Joint cartilage matrix glycan (GAGs/Aggrecan) repair and lubrication

★★★☆☆Mechanism evidence: grade CSecondary target

A rat study showed less histological worsening of cartilage after oral UC-II. CTX-II changes were seen in some human subgroups with a different native type II collagen, but that preparation is not the same, so the result cannot be applied directly to UC-II. Better symptom scores also do not prove that the cartilage matrix was repaired.

References (2)
  1. Bagi 2017 · Rat study: oral UC-II reduced histological worsening of cartilage.
  2. Möller 2026 · Human RCT: another native type II collagen produced CTX-II changes in some subgroups; the product used was a different brand from this one.

Safety and drug interactions

Use with caution if you have a severe allergy to chicken or poultry protein, and check the source material and the specific product before taking it. The native triple-helix structure needs to stay intact, so do not chew it or stir it into boiling water.
Open in the interactive app ›